Please use this identifier to cite or link to this item:
http://localhost:80/xmlui/handle/123456789/3383
Title: | Clinical utility of the interaction between lectin and serum prostate specific antigen in prostate cancer |
Other Titles: | (In) Neoplasma |
Authors: | BATABYAL, S. K. MAJHI, R. BASU, P. S. |
Keywords: | Prostate Cancer BPH PSA Lectin |
Issue Date: | 2009 |
Series/Report no.: | Vol. 56;No. 1 |
Abstract: | The present investigation was a lectin-based diagnosis of malignant prostate cancer (PC) by the interaction of phytohemagglutinin (PHA lectin) from Phaseolus vulgaris with the glycan part of serum prostate specific antigen (PSA ) of patients with prostatic disorder. This was confirmed by the interaction between PHA and purified PSA obtained from serum by electrophoretic separation and finally by HPL C chromatography. The precipitate of carbohydrate content after binding of PHA with purified PSA of PC was significantly higher than that of benign prostate hyperplasia (BPH) and/or normal serum PSA . The results suggest that there may be a striking difference in glycosylation pattern of PSA between BPH and PC. The cut off value ≥ 10 μg/ml of the carbohydrate content of PHA-PSA precipitate indicates strong suspicion for PC irrespective of total serum PSA cut off level ≥ 4.0ng/ml by conventional immunoassay method and this may be taken as a guideline in differentiating PC and BPH. |
URI: | 10.4149/neo_2009_01_68 http://172.16.0.4:8085/heritage/handle/123456789/3383 |
Appears in Collections: | Biotechnology (Publications) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Clinical utility of the interaction between lectin and serum prostate.pdf | 37.68 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.